Investigating how ‘chemo brain’ develops in cancer patients

Studies have estimated that up to one-third of chemotherapy patients experience a change in their cognitive abilities. The complication can include memory lapses, trouble concentrating and difficulty remembering common words. Scientists have proposed that the chemotherapy drugs could cause the symptoms by restricting blood flow in the brain or interfering with chemical signaling. Michael A. … Continue reading “Investigating how ‘chemo brain’ develops in cancer patients”

Studies have estimated that up to one-third of chemotherapy patients experience a change in their cognitive abilities. The complication can include memory lapses, trouble concentrating and difficulty remembering common words. Scientists have proposed that the chemotherapy drugs could cause the symptoms by restricting blood flow in the brain or interfering with chemical signaling. Michael A. Johnson and colleagues at the University of Kansas wanted to investigate how carboplatin therapy — commonly given to patients with breast, bladder, colon and other cancers — affects dopamine and serotonin.

The researchers administered carboplatin to rats over four weeks and found that the release and uptake of both dopamine and serotonin in their brains became sluggish after treatment. Also, the treated rats appeared to have cognitive issues. The results suggest that impaired neurotransmitter release and uptake could play a role in the development of chemo brain, although more work is needed to further pin down the mechanism, the researchers say.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply